Cargando…
Comparison between conventional and "clinical" assessment of experimental lung fibrosis
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a treatment resistant disease with poor prognosis. Numerous compounds have been demonstrated to efficiently prevent pulmonary fibrosis (PF) in animal models but only a few were successful when given to animals with established fibrosis. Major concer...
Autores principales: | Ask, Kjetil, Labiris, Renee, Farkas, Laszlo, Moeller, Antje, Froese, Aaron, Farncombe, Troy, McClelland, Grant B, Inman, Mark, Gauldie, Jack, Kolb, Martin RJ |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365932/ https://www.ncbi.nlm.nih.gov/pubmed/18402687 http://dx.doi.org/10.1186/1479-5876-6-16 |
Ejemplares similares
-
A new direction in the pathogenesis of idiopathic pulmonary fibrosis?
por: Gauldie, Jack, et al.
Publicado: (2002) -
Micro-computed tomography of pulmonary fibrosis in mice induced by adenoviral gene transfer of biologically active transforming growth factor-β1
por: Rodt, Thomas, et al.
Publicado: (2010) -
Role of matrix metalloprotease-2 and MMP-9 in experimental lung fibrosis in mice
por: Bormann, Tina, et al.
Publicado: (2022) -
Circulating fibrocytes are not disease-specific prognosticators in idiopathic pulmonary fibrosis
por: Stewart, Iain D., et al.
Publicado: (2021) -
Medical imaging: technology and applications
por: Farncombe, Troy, et al.
Publicado: (2014)